Abbott, Pfizer in pact for lung cancer screening
August 27th, 2009
CHICAGO (Reuters) – An Abbott Laboratories Inc unit that makes genetic tests will work with Pfizer Inc to develop a test to screen non-small cell lung cancer (NSCLC) tumors to determine which patients are good candidates for a novel cancer therapy being developed by Pfizer.